middle.news
Entropy’s TRP-8803 Response Holds After 12 Weeks in BED Trial
8:40am on Monday 14th of September, 2026 AEST
•
Biotechnology
Read Story
Entropy’s TRP-8803 Response Holds After 12 Weeks in BED Trial
8:40am on Monday 14th of September, 2026 AEST
Key Points
100% of patients maintained clinically meaningful improvement
50% achieved full remission over 12 weeks
Weekly binge-eating episodes remained 73% below baseline
Two IV psilocin treatments produced sustained response
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Entropy Neurodynamics (ASX:ENP)
OPEN ARTICLE